Signaturefd, LLC Sage Therapeutics, Inc. Transaction History

Signaturefd, LLC

$4.91 Billion
Q2 2024

A detailed history of Signaturefd, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 446 shares of SAGE stock, worth $3,104. This represents 0.0% of its overall portfolio holdings.

Number of Shares

446

Previous 345 29.28%

Holding current value

$3,104

Previous $6,000 33.33%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$10.58 - $17.9 $1,068 - $1,807	101 Added 29.28%	446 $4,000
Q1 2024 May 03, 2024	SELL	$18.62 - $26.95 $3,556 - $5,147	-191 Reduced 35.63%	345 $6,000
Q4 2023 Jan 31, 2024	BUY	$17.1 - $22.26 $6,104 - $7,946	357 Added 199.44%	536 $11,000
Q3 2023 Nov 03, 2023	SELL	$16.75 - $48.98 $2,043 - $5,975	-122 Reduced 40.53%	179 $3,000
Q2 2023 Aug 01, 2023	SELL	$40.65 - $59.54 $3,495 - $5,120	-86 Reduced 22.22%	301 $14,000
Q1 2023 Apr 28, 2023	BUY	$37.27 - $46.57 $2,459 - $3,073	66 Added 20.56%	387 $16,000
Q4 2022 Jan 27, 2023	SELL	$32.2 - $43.61 $3,381 - $4,579	-105 Reduced 24.65%	321 $12,000
Q3 2022 Nov 08, 2022	BUY	$32.28 - $43.27 $3,066 - $4,110	95 Added 28.7%	426 $17,000
Q2 2022 Aug 10, 2022	BUY	$27.52 - $37.99 $9,109 - $12,574	331 New	331 $11,000
Q1 2022 May 02, 2022	SELL	$30.71 - $45.71 $429 - $639	-14 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$37.06 - $47.11 $481 - $612	-13 Reduced 48.15%	14 $1,000
Q3 2021 Oct 28, 2021	SELL	$40.26 - $57.37 $2,294 - $3,270	-57 Reduced 67.86%	27 $1,000
Q2 2021 Jul 26, 2021	SELL	$54.88 - $79.29 $439 - $634	-8 Reduced 8.7%	84 $5,000
Q4 2020 Feb 11, 2021	SELL	$58.41 - $89.06 $10,747 - $16,387	-184 Reduced 66.67%	92 $8,000
Q3 2020 Nov 03, 2020	BUY	$41.13 - $62.45 $3,125 - $4,746	76 Added 38.0%	276 $17,000
Q1 2020 Apr 23, 2020	BUY	$26.15 - $77.24 $5,230 - $15,447	200 New	200 $6,000

Others Institutions Holding SAGE

# of Institutions

217

Shares Held

48.2M

Call Options Held

854K

Put Options Held

195K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $414M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account